Picture Name

HUAREN MEDICAL TECHNOLOGY

NEWS

26

2022-04

Genetic testing, a game changer


Do you wish to foretell tomorrow, or do you prefer to be ready for the surprises or scares that fate gives you? With genetic testing, we will have the language of life. Know your enemy, know yourself, and seize the opportunity to control your destiny!

View More

16

2022-04

Vigilance! New Coronavirus May Cause Male Reproductive Damage


In January 2020, academician Zhong Nanshan suggested that the new coronavirus had appeared as a human-to-human transmission phenomenon, and since then, our lives have changed drastically, as the new coronavirus has caused devastation around the world, and people's lives have come to a halt for a while. Until the end of 2020, the launch of the new coronavirus vaccine gave people hope to defeat the virus.

View More

16

2022-04

Leaders of Guangxi Academy of Sciences Institute of Medicine and Health visited Guangxi International Zhuang Medicine Hospital!


On April 14, 2022, Ji Feng, president of Guangxi Academy of Sciences Institute of Medicine and Health, and his party visited Guangxi International Zhuang Medical Hospital and carried out a symposium, which was attended by Yue Guihua, president of Guangxi International Zhuang Medical Hospital, and Huang Guodong, vice president of Guangxi International Zhuang Medical Hospital.

View More

16

2022-04

NK cells can be used in consolidation therapy for multiple myeloma


To date, multiple myeloma remains an incurable disease and autologous haematopoietic stem cell transplantation is one of the mainstays of treatment, often followed by long-term maintenance therapy with immunomodulators or proteasome inhibitors. However, due to the average age of patients receiving a diagnosis of 65-70 years, the use of autologous HSCT therapy to achieve long-term control of disease progression is not realistic. In addition, there are many serious side effects associated with the long-term use of maintenance therapy, including the risk of haematopenia, thrombosis, secondary malignancy and neuropathy. A promising approach is the use of alternative cell therapy as consolidation after autologous HSCT, which does not have the side effects of maintenance therapy.

View More

09

2022-04

New developments in organ transplantation! Universal blood group organ promises to solve matching challenges


As we all know, when we have a blood transfusion, the doctor needs to know your blood type and choose the same blood type in order not to cause serious blood clotting, a life-threatening symptom; however, there is also a special blood type - blood type O. Since there are no A antigens and B antigens on the red blood cells of blood type O, it does not cause an immune response, which is also known as universal blood.

View More

03

2022-04

Treatment of a common disease of ageing: "New weapon" for dry eye - NAD+


NAD+, a key metabolite of the cellular universal currency, has attracted a lot of attention in the scientific community over the past few years for its ability to prevent or delay the progression of aging-related diseases. Studies from many laboratories around the world have identified the role of NAD+-regulated pathways in the prevention of cellular senescence, such as energy metabolism, DNA damage repair, epigenetic modifications, gene expression and stress responses.

View More
< 1...151617...22 >